Medical News

RSS

Cytori Therapeutics' PureGraft System receives FDA marketing clearance

The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient’s own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.

9 Jan 2010

Seven new biopharmaceutical companies join PhRMA, Forbes reports

Forbes recently reported that seven new biopharmaceutical companies have now joined the Pharmaceutical Research and Manufacturers of America (PhRMA).

From CSL Ltd 9 Jan 2010

Primer: House vs. Senate health bill

"Most of the two bills' provisions are similar, and the cost estimates are in the range Democrats have sought. According to the nonpartisan Congressional Budget Office, the House bill would reduce the federal deficit by $130 billion over the next 10 years, while the Senate would cut it $132 billion. Some difficult controversies remain.

9 Jan 2010

Study: Reform bills could save health care dollars

The Los Angeles Times: "National healthcare legislation in Congress could slow the growth of medical costs, allowing employers to create 250,000 to 400,000 new jobs a year over the next decade, economists from Harvard University and USC are predicting.

9 Jan 2010

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

St. Andrews Country Club of Boca Raton members teamed up with LPGA Tour player Morgan Pressel this week to raise $405,000 through the 3rd annual 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer through early detection and treatment.

9 Jan 2010

Centron receives agency of record assignments for FRAGMIN and GLIADEL Wafer medicines

HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.

9 Jan 2010

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

9 Jan 2010

Study finds patients more likely to skip diabetes medicine while in the 'doughnut hole'

Consumers experiencing a gap in their Medicare Part D prescription drug coverage were more likely to forgo diabetes medications than those who had supplemental drug benefits.

9 Jan 2010

LehmanMillet honored with four prestigious industry awards

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced it has won four prestigious industry awards: an MM&M (Medical Marketing & Media Magazine) Gold Award for work done on behalf of Abbott Nutrition; a First Place DxMA (Diagnostic Marketing Association) award for work done on behalf of Abbott Diagnostics; a First Place DxMA Award for work done on behalf of BRAHMS USA; and a PM360 Pharma Choice Bronze Award.

9 Jan 2010

Today's opinions and editorials

Californians need to ask themselves why, when other states and the federal government are making children's health a priority, the Golden State may be adding another half-million children … to the ranks of the uninsured next year (1/7).

9 Jan 2010

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems, Inc. is pleased to announce that it has initiated its European clinical trial at the Thoraxcenter Research Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW) cobalt–chromium Bare Metal Stent.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

Economist examines innovative mechanisms for funding global health programs

The Economist examines the "dramatic" change in funding for projects aimed at fighting diseases in the developing world. "In 1990 more than two-thirds of the $5.6 billion spent on global health assistance came from governments.

9 Jan 2010

Labopharm settles $1 million standby equity distribution with YA Global Master SPV

Labopharm Inc. today announced it has settled the previously announced draw down of $1 million under its standby equity distribution (SEDA) with YA Global Master SPV Ltd. (YA). Under the draw down, Labopharm issued 482,165 of its common shares to YA at a price of $2.07 per common share, net of the applicable discount. (All currency figures are in Canadian dollars.)

9 Jan 2010

Trim Holding Group purchases patent rights under patent agreement with Allkey

Trim Holding Group ("the Company") announced that on December 31, 2009 the Company purchased patent rights under a patent agreement signed with Allkey Ltd. In consideration of the patent rights, the Company issued 3,750,000 preferred shares with a par value of $7.00/share.

9 Jan 2010

One million seniors get more generous prescription drug benefits

As of Jan. 1, more than 1 million low-income seniors "are newly eligible for more generous prescription drug benefits under the 'extra help' program" in Medicare, The Associated Press reports.

9 Jan 2010

Misonix signs new distribution agreement with Thimar Al Jazirah Health Care

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Thimar Al Jazirah Health Care, based in Riyadh, Kingdom of Saudi Arabia, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter.

9 Jan 2010

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.

9 Jan 2010

Luna Innovations extends its development and supply agreement with Intuitive Surgical

Luna Innovations Incorporated announced today that it will be extending its development and supply agreement with Intuitive Surgical, Inc. (NASDAQ: ISRG) to continue integrating Luna’s shape sensing technology into Intuitive’s products.

8 Jan 2010

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.

8 Jan 2010

Medical News

Cytori Therapeutics' PureGraft System receives FDA marketing clearance

Seven new biopharmaceutical companies join PhRMA, Forbes reports

Primer: House vs. Senate health bill

Study: Reform bills could save health care dollars

St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fight breast cancer

Centron receives agency of record assignments for FRAGMIN and GLIADEL Wafer medicines

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Study finds patients more likely to skip diabetes medicine while in the 'doughnut hole'

LehmanMillet honored with four prestigious industry awards

Today's opinions and editorials

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Economist examines innovative mechanisms for funding global health programs

Labopharm settles $1 million standby equity distribution with YA Global Master SPV

Trim Holding Group purchases patent rights under patent agreement with Allkey

One million seniors get more generous prescription drug benefits

Misonix signs new distribution agreement with Thimar Al Jazirah Health Care

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Luna Innovations extends its development and supply agreement with Intuitive Surgical

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News